Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 17 , ISSUE 3 ( June, 2013 ) > List of Articles

CASE REPORT

All that seems sepsis is not sepsis

Vivek S. Guleria, Prabhat Chauhan, Subramanian Shankar

Keywords : Catastrophic antiphospholipid syndrome, sepsis, systemic lupus erythematosus

Citation Information : Guleria VS, Chauhan P, Shankar S. All that seems sepsis is not sepsis. Indian J Crit Care Med 2013; 17 (3):185-187.

DOI: 10.4103/0972-5229.117077

License: CC BY-ND 3.0

Published Online: 01-06-2013

Copyright Statement:  Copyright © 2013; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Catastrophic antiphospholipid antibody syndrome (CAPS) resembles severe sepsis in its acute presentation, with features of systemic inflammatory response syndrome (SIRS) leading to multiple organ dysfunction. Infections are the best known triggers of CAPS. This emphasizes the need for early diagnosis and aggressive treatment as the mortality is as high as 50%. We present a 42-year-old woman who developed SIRS postoperatively and was eventually diagnosed as CAPS.


PDF Share
  1. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019-27.
  2. Erkan D, Cervera R, Asherson RA. Catastrophic antiphospholipid syndrome: Where do we stand? Arthritis Rheum 2003;48:3320-7.
  3. Pierangeli S, Chen PP, González EB. Antiphospholipid antibodies and the antiphospholipid syndrome: An update on treatment and pathogenic mechanisms. Curr Opin Hematol 2006;13:366-75.
  4. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992;19:508-12.
  5. Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, et al. Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines. Lupus 2003;12:530-4.
  6. Asherson RA, Shoenfeld Y. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome-molecular mimicry? J Rheumatol 2000;27:12-4.
  7. Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 2006;65:2-6.
  8. Meroni PL, Raschi E, Testoni C, Parisio A, Borghi MO. Innate immunity in the antiphospholipid syndrome: Role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies. Autoimmun Rev 2004;3:510-5.
  9. Galli M, Finazzi G, Barbui T. Thrombocytopenia in the antiphospholipid syndrome. Brit J Haem 1996;93:1-5.
  10. Asherson RA, Cervera R, Piette JC, Font J, Lie JT, Burcoglu A, et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998;77:195-207.
  11. Asherson RA, Cervera R, Piette JC, Shoenfeld Y, Espinosa G, Petri MA, et al. Catastrophic antiphospholipid syndrome: Clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001;80:355-77.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.